United States

The Root Causes of the Innovation Gap in Women’s Health

Dr. Dina Radenkovic, CEO of Gameto, discusses the company's pioneering use of induced pluripotent stem cell (iPSC) technology in fertility treatments, particularly addressing ovarian aging. Its lead product, Fertilo, is an iPSC-derived ovarian support cell line in phase III clinical trials in the US with FDA clearance, and commercial availability in markets like Australia and Latin America. The company faces challenges including the scarcity of human eggs and regulatory hurdles. Radenkovic also highlights the need for better models to study female-specific conditions and the importance of political advocacy and funding to drive innovation in women's health.
Read More

How federal funding cuts for biomedical research impact reproductive health

Reproductive health is historically understudied and underfunded in the United States. Scientists across Connecticut and beyond have been working to change that. Scientific initiatives like EndoRISE, a Connecticut-based program focused on advancing endometriosis research, are making strides toward better understanding reproductive health. This hour, we explore how President Trump’s recent funding cuts could impact their progress.
Read More

The Collateral Damage of Dobbs on Women’s Health: Beyond Abortion Care

When the Supreme Court overturned Roe v. Wade, it upended half a century of established jurisprudence – leaving in its wake a convoluted legal landscape, and eliminating access to vital reproductive care for millions. The fallout includes a wider range of health issues affecting women undergoing cancer treatment, using assisted fertility, entering menopause, and more
Read More

OB/GYNs Walk Away From Anti-Abortion States

They compared the number of those specialists to state-level abortion policy data collected using a legislation tracker maintained by the Guttmacher Institute, a nonprofit sexual and reproductive rights advocacy group. Researchers specifically focused on 12 states that restricted abortion most following the U.S. Supreme Court's Dobbs v Jackson Women’s Health Organization decision in 2022 -- Alabama, Arkansas, Idaho, Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, South Dakota, Tennessee, Texas and West Virginia.
Read More

OB/GYNs ‘vote with their feet’ as workforce declines in states that restricted abortion

“Modest but significant decreases in OB/GYN practitioners occurred in states with full abortion bans following the 2022 U.S. Supreme Court decision in Dobbs v. Jackson Women’s Health Association, a study showed. However, results of the case-control study revealed the workforce of such practitioners ultimately grew overall across all states…”
Read More

Abortion bans are changing career calculations for workers who want kids

“Employers are navigating a complex benefits landscape when it comes to reproductive health, as they seek to comply with various state laws restricting abortion while ensuring their employees can still access care they need. A recent survey finds reproductive health access is top-of-mind for US adults, and this has implications for HR leaders. Abortion restrictions are prompting some adults to relocate, while reproductive health benefits are proving to be a key factor for job-seekers as they weigh whether to apply for or accept a role. How reproductive healthcare policies are affecting workers, job-seekers. One in five adults planning to have children…
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.